Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,749.00
Bid: 1,749.00
Ask: 1,750.00
Change: 15.50 (0.89%)
Spread: 1.00 (0.057%)
Open: 1,736.00
High: 1,751.50
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Markets lifted by corporate earnings, China outlook

Thu, 24th Oct 2013 16:22

- FTSE 100 at levels not seen since May- China manufacturing PMI at seven-month high- Financials, miners and pharma stocks gaintechMARK 2,642.27 +0.68%FTSE 100 6,713.18 +0.58%FTSE 250 15,526.93 +0.21%UK markets set a fresh five-month high on Thursday as investors celebrated an improved outlook for China and digested a host of upbeat corporate earnings from across the globe.Strong gains amongst financials, miners and pharmaceutical stocks helped the FTSE 100 higher today, along with upbeat results from blue chips Shire and WPP. Strong earnings from US giants Ford and 3M and European peers Daimler and ABB also gave sentiment a boost on global equity markets today.London's benchmark index finished up 38.7 points at 6,713.18; it has not closed above this level since May 28th when it finished at 6,762.01.Global equity markets were on the up after figures from HSBC and Markit showed that activity in China's manufacturing sector rose to a seven-month high. The manufacturing purchasing managers' index (PMI) increased from 50.2 to 50.9, ahead of the consensus forecast of 50.4."Anything that's good for Chinese growth is viewed as positive for the global economy, which is why we're seeing European indices on the rise again [...] following the brief pull back yesterday," said Market Analyst Craig Erlam from Alpari.Markets largely shrugged off the Eurozone composite PMI, which measures activity in both the services and manufacturing sectors, as it unexpectedly fell from 52.2 to 51.5 in October. Nevertheless, the index remains in growth territory (above 50), which is likely to lift confidence as the region moves out of recession.Shire surges after Q3 beatDrugmaker Shire climbed after it increased its full-year earnings growth guidance from "double digit" to "mid-to-high teens" following a better-than-expected third quarter. Heavyweight pharmaceutical peers GlaxoSmithKline and AstraZeneca were also providing a lift on markets this afternoon.Aberdeen Asset Management was a high riser on the news it was in talks with Lloyds for the potential acquisition of Scottish Widows Investment Partnership. Lloyds, along with banking peers Standard Chartered, RBS and HSBC, were also in demand, as banks rebounded after the announcement of European Central Bank stress tests scared investors yesterday. The mining sector was putting in a decent performance today as stocks tracked metal prices higher and celebrated the improved outlook for China. Fresnillo and Vedanta were registering decent gains by the close.Advertising giant WPP advanced after reporting a 7.2% rise in revenue to £8.2bn in the first nine months on the back of acquisitions and new business wins.Ophir Energy jumped after confirming reports that it will sell a part interest in gas field blocks one, three and four in Tanzania.Heading the other way was High Street retailer Sports Direct which sank sharply after MASH Holdings, a company wholly owned by founder and Deputy Chairman Mike Ashley, sold 16m shares (a 2.7% stake) at 662.5p each, a 7.5% discount to Wednesday's closing price. The £106m sale reduced MASH's holding to 61.7%.Meanwhile, Debenhams tanked after saying it expects the retail marketplace to remain "highly competitive" as it reported full-year profits fell 2.7% to £154m.FTSE 100 - RisersShire Plc (SHP) 2,760.00p +9.31%Aberdeen Asset Management (ADN) 450.40p +5.83%Lloyds Banking Group (LLOY) 80.12p +2.84%Fresnillo (FRES) 1,022.00p +2.82%Petrofac Ltd. (PFC) 1,462.00p +2.67%Rolls-Royce Holdings (RR.) 1,174.00p +2.62%Vedanta Resources (VED) 1,088.00p +2.16%GlaxoSmithKline (GSK) 1,597.00p +1.69%British Land Co (BLND) 623.00p +1.63%GKN (GKN) 376.20p +1.57%FTSE 100 - FallersSports Direct International (SPD) 685.00p -3.79%William Hill (WMH) 388.60p -2.61%Marks & Spencer Group (MKS) 476.70p -1.79%Tullow Oil (TLW) 959.00p -1.44%Kingfisher (KGF) 367.90p -1.37%ITV (ITV) 192.60p -1.23%Centrica (CNA) 356.70p -1.03%Diageo (DGE) 2,012.50p -0.81%Severn Trent (SVT) 1,860.00p -0.80%Next (NXT) 5,210.00p -0.76%FTSE 250 - RisersOphir Energy (OPHR) 326.70p +9.12%Ferrexpo (FXPO) 196.10p +6.17%Kazakhmys (KAZ) 265.00p +5.41%Hochschild Mining (HOC) 168.50p +5.38%Inchcape (INCH) 644.50p +3.53%Essar Energy (ESSR) 123.50p +2.75%Man Group (EMG) 90.45p +2.67%Serco Group (SRP) 552.50p +2.31%TR Property Inv Trust (TRY) 231.00p +2.30%Rank Group (RNK) 153.80p +2.19%FTSE 250 - FallersDebenhams (DEB) 101.00p -8.76%Spirent Communications (SPT) 118.20p -4.29%Petra Diamonds Ltd.(DI) (PDL) 118.20p -3.35%Fisher (James) & Sons (FSJ) 1,082.00p -3.31%Cranswick (CWK) 1,064.00p -3.18%Euromoney Institutional Investor (ERM) 1,020.00p -3.13%Ocado Group (OCDO) 421.10p -2.97%Genus (GNS) 1,335.00p -2.84%Millennium & Copthorne Hotels (MLC) 599.50p -2.60%Alent (ALNT) 346.00p -2.54%BC
More News
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.